Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2004 1
2012 1
2016 1
2017 8
2018 52
2019 1345
2020 10542
2021 34
Text availability
Article attribute
Article type
Publication date

Search Results

10,542 results
Results by year
Filters applied: . Clear all
Page 1
The Impact of the COVID-19 Pandemic on Cancer Patients.
Al-Quteimat OM, Amer AM. Al-Quteimat OM, et al. Am J Clin Oncol. 2020 Jun;43(6):452-455. doi: 10.1097/COC.0000000000000712. Am J Clin Oncol. 2020. PMID: 32304435 Free PMC article. Review.
Currently, there is no specific treatment or approved vaccine against COVID-19 and many clinical trials are currently investigating potential medications to treat COVID-19. The immunosuppressed status of some cancer patients (whether caused by the disease itself or the tre …
Currently, there is no specific treatment or approved vaccine against COVID-19 and many clinical trials are currently investigating potentia …
Role of RNA modifications in cancer.
Barbieri I, Kouzarides T. Barbieri I, et al. Nat Rev Cancer. 2020 Jun;20(6):303-322. doi: 10.1038/s41568-020-0253-2. Epub 2020 Apr 16. Nat Rev Cancer. 2020. PMID: 32300195 Review.
Many of the enzymes responsible for regulating protein and DNA modifications are targets of current cancer therapies. RNA epitranscriptomics, the study of RNA modifications, is the new frontier of this arena. ...Increasing evidence suggests that RNA modification pathways a …
Many of the enzymes responsible for regulating protein and DNA modifications are targets of current cancer therapies. RNA epitranscri …
Cancer Incidence and Trends.
Hulvat MC. Hulvat MC. Surg Clin North Am. 2020 Jun;100(3):469-481. doi: 10.1016/j.suc.2020.01.002. Epub 2020 Mar 27. Surg Clin North Am. 2020. PMID: 32402294 Review.
The incidence of many types of cancer continues to increase, and despite many successes in the realms of screening, prevention, and treatment, cancer remains the second leading cause of death in North America. ...These cancer survivors face unique challenges …
The incidence of many types of cancer continues to increase, and despite many successes in the realms of screening, prevention, and t …
Anal Cancer.
Young AN, Jacob E, Willauer P, Smucker L, Monzon R, Oceguera L. Young AN, et al. Surg Clin North Am. 2020 Jun;100(3):629-634. doi: 10.1016/j.suc.2020.02.007. Epub 2020 Mar 27. Surg Clin North Am. 2020. PMID: 32402305 Review.
Anal cancer is a rare cancer, comprising less than 5% of gastrointestinal tract malignancies. Diagnosis of anal canal cancer can be difficult given that presenting symptoms are similar to those of benign anorectal diseases. ...
Anal cancer is a rare cancer, comprising less than 5% of gastrointestinal tract malignancies. Diagnosis of anal canal cance
Overview of VI-RADS in Bladder Cancer.
Pecoraro M, Takeuchi M, Vargas HA, Muglia VF, Cipollari S, Catalano C, Panebianco V. Pecoraro M, et al. AJR Am J Roentgenol. 2020 Jun;214(6):1259-1268. doi: 10.2214/AJR.20.22763. Epub 2020 Apr 14. AJR Am J Roentgenol. 2020. PMID: 32286874 Review.
The purpose of this article is to review the natural history and management of bladder cancer, with insight into MRI applications for the assessment of muscle invasiveness of bladder cancer using the newly developed Vesical Imaging Reporting and Data System (VI-RADS …
The purpose of this article is to review the natural history and management of bladder cancer, with insight into MRI applications for …
Lineage plasticity in cancer: a shared pathway of therapeutic resistance.
Quintanal-Villalonga Á, Chan JM, Yu HA, Pe'er D, Sawyers CL, Sen T, Rudin CM. Quintanal-Villalonga Á, et al. Nat Rev Clin Oncol. 2020 Jun;17(6):360-371. doi: 10.1038/s41571-020-0340-z. Epub 2020 Mar 9. Nat Rev Clin Oncol. 2020. PMID: 32152485 Free PMC article. Review.
Tumour cell conversion into a different histological subtype has been associated with a loss of dependency on the original oncogenic driver, leading to therapeutic resistance. A well-known pathway of lineage plasticity in cancer - the histological transformation of adenoca …
Tumour cell conversion into a different histological subtype has been associated with a loss of dependency on the original oncogenic driver, …
Cell competition and tumor heterogeneity.
Parker TM, Henriques V, Beltran A, Nakshatri H, Gogna R. Parker TM, et al. Semin Cancer Biol. 2020 Jun;63:1-10. doi: 10.1016/j.semcancer.2019.09.003. Epub 2019 Sep 9. Semin Cancer Biol. 2020. PMID: 31513848 Review.
Cancers exhibit a remarkable degree of intratumoral heterogeneity (ITH), which results from complex cellular interactions amongst various cell types. This phenomenon provides an opportunity for clonal selection and growth advantages to aggressive cancer cell types,
Cancers exhibit a remarkable degree of intratumoral heterogeneity (ITH), which results from complex cellular interactions amongst var
Review of precision cancer medicine: Evolution of the treatment paradigm.
Tsimberidou AM, Fountzilas E, Nikanjam M, Kurzrock R. Tsimberidou AM, et al. Cancer Treat Rev. 2020 Jun;86:102019. doi: 10.1016/j.ctrv.2020.102019. Epub 2020 Mar 31. Cancer Treat Rev. 2020. PMID: 32251926 Free PMC article. Review.
The majority of these trials demonstrated that matched therapy is associated with superior outcomes compared to non-matched therapy across tumor types and in specific cancers. To improve the implementation of precision medicine, this approach should be used early in the co …
The majority of these trials demonstrated that matched therapy is associated with superior outcomes compared to non-matched therapy across t …
COX-2-PGE(2)-EPs in gynecological cancers.
Ye Y, Wang X, Jeschke U, von Schönfeldt V. Ye Y, et al. Arch Gynecol Obstet. 2020 Jun;301(6):1365-1375. doi: 10.1007/s00404-020-05559-6. Epub 2020 May 3. Arch Gynecol Obstet. 2020. PMID: 32363546 Free PMC article. Review.
PURPOSE: Nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors (COXibs) inhibit the progression of endometrial cancer, ovarian cancer and cervical cancer. However, concerning the adverse effects of NSAIDs and COXibs, it is still urgent …
PURPOSE: Nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors (COXibs) inhibit the progression of endometrial can
Cancer Genetics.
Van Cott C. Van Cott C. Surg Clin North Am. 2020 Jun;100(3):483-498. doi: 10.1016/j.suc.2020.02.012. Epub 2020 Apr 16. Surg Clin North Am. 2020. PMID: 32402295 Review.
For most individuals, cancer development is multifactorial; however, up to 10% of all cancers are related to an inherited genetic mutation. As health care shifts to having a greater emphasis on prevention, care providers, including general surgeons, will need to pla …
For most individuals, cancer development is multifactorial; however, up to 10% of all cancers are related to an inherited gene …
10,542 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page